Atlas Trials

A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology

Clinical trial NCT06662071 · RECRUITING

Trial details

NCT number
NCT06662071
Sponsor
Qilu Hospital of Shandong University
Status
RECRUITING
Study type
OBSERVATIONAL
Bladder Cancer
Start date
2024-10-01
Primary completion
2028-09-30
Enrollment
293

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.